Vanguard FTSE Developed Europe UCITS ETF
(VWCG) Vanguard FTSE Developed Europe UCITS ETF - (EUR) Accumulating
Related documents
About this fund
Fund objectives
- The Fund employs a passive management – or indexing – investment approach, through physical acquisition of securities, and seeks to track the performance of the FTSE Developed Europe Index (the “Index”).
- The Index is comprised of large and mid-sized company stocks in developed markets in Europe.
- The Fund attempts to: 1. Track the performance of the Index by investing in all constituent securities of the Index in the same proportion as the Index. Where not practicable to fully replicate, the Fund will use a sampling process. 2. Remain fully invested except in extraordinary market, political or similar conditions.
Why this fund
- The Fund seeks to provide long-term growth of capital by tracking the performance of the index, a market-capitalisation-weighted index of common stocks of large- and mid-cap companies in sixteen developed European countries.
- The Fund employs a passive management or indexing investment approach through the physical acquisition of securities, designed to track the performance of the index, a free-float market-capitalisation-weighted index.
- The Fund will invest in a portfolio of securities that, so far as possible and practicable, consists of the component securities of the index.
- Low expenses minimise net tracking error.
Fund facts
Share class inception
Jul 23 2019
Listing date
Jul 25 2019
Investment structure
Irish UCITS
Share class assets'
Total assets
Risk indicator
Strategy
Index
Asset class
Equity
Investment Method
Physical
Index ticker
TAWNT06E
Benchmark
FTSE Developed Europe Index
Dividend Schedule
—
Tax status
Austria, Germany, Switzerland and United Kingdom
Domicile
Ireland
Legal Entity
Vanguard Funds PLC
The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.
Performance
Risk and Volatility
As at Sep 30 2026
Beta
R²
Alpha
Standard Deviation
Sharpe Ratio
Portfolio data
Characteristics
| Fundamentals | Fund | Benchmark | As at |
|---|---|---|---|
| Number of stocks | 509 | 493 | Sep 30 2026 |
| Median market capital | 86.7 B | 86.7 B | Sep 30 2026 |
| 17.0 x | 17.1 x | Sep 30 2026 | |
| 2.4 x | 2.4 x | Sep 30 2026 | |
| 14.0% | 14.0% | Sep 30 2026 | |
| 10.2% | 10.2% | Sep 30 2026 | |
| Portfolio turnover rate | -14.3% | — | Sep 30 2026 |
Market allocation
As at Sep 30 2026
| Country | Region | Fund | Benchmark | Variance +/- |
|---|---|---|---|---|
| United Kingdom | Europe | 22.84% | 22.84% | 0.00% |
| France | Europe | 14.09% | 14.09% | 0.00% |
| Swiss | Europe | 14.05% | 14.05% | 0.00% |
| Germany | Europe | 13.29% | 13.29% | 0.00% |
| Netherlands | Europe | 8.75% | 8.75% | 0.00% |
| España | Europe | 6.28% | 6.28% | 0.00% |
| Italia | Europe | 5.61% | 5.61% | 0.00% |
| Suecia | Europe | 5.06% | 5.06% | 0.00% |
| Dinamarca | Europe | 2.38% | 2.38% | 0.00% |
| Finlandia | Europe | 1.80% | 1.80% | 0.00% |
| Belgium | Europe | 1.76% | 1.76% | 0.00% |
| Noruega | Europe | 1.04% | 1.04% | 0.00% |
| Polonia | Europe | 0.88% | 0.88% | 0.00% |
| Austria | Europe | 0.69% | 0.69% | 0.00% |
| Irlanda | Europe | 0.62% | 0.62% | 0.00% |
Top 10 Holdings
As at Sep 30 2026
| Holding name | % of market value | Sector | Region | Market value | Shares |
|---|---|---|---|---|---|
| ASML Holding NV | 4.87519% | Technology | NL | €380,439,196.80 | 238,251 |
| HSBC Holdings PLC | 2.37768% | Financials | GB | €185,544,247.73 | 10,593,207 |
| Roche Holding AG | 2.04892% | Health Care | CH | €159,888,862.03 | 434,360 |
| Shell PLC | 1.92845% | Energy | GB | €150,487,725.73 | 3,604,703 |
| Novartis AG | 1.86681% | Health Care | CH | €145,678,004.92 | 1,151,699 |
| AstraZeneca PLC | 1.70405% | Health Care | GB | €132,976,509.53 | 925,875 |
| Nestle SA | 1.63205% | Consumer Staples | CH | €127,357,858.67 | 1,588,837 |
| Siemens AG | 1.58198% | Industrials | DE | €123,451,274.50 | 448,099 |
| SAP SE | 1.43590% | Technology | DE | €112,051,379.80 | 603,530 |
| Banco Santander SA | 1.40888% | Financials | ES | €109,942,940.87 | 8,918,149 |
Prices and distribution
Prices
NAV Price (EUR)
€59.98
EURChange
+€0.050.08% As at Oct 28 2026
Market price (EUR)
€60.59
Change
+€0.500.83% As at Oct 29 2026
NAV 52-week high
€61.34
As at Oct 29 2026
Market price 52-week high
€61.49
As at Oct 29 2026
NAV 52-week low
€50.93
As at Oct 29 2026
Market price 52-week low
€51.01
As at Oct 29 2026
NAV 52-week difference
€10.41
Change
+16.97% As at Oct 29 2026
Market price 52-week difference
€10.48
Change
+17.04% As at Oct 29 2026
Outstanding shares
51,397,547
As at Sep 30 2026
Discount
€0.61
Change
+1.01% As at Oct 29 2026
Historical Prices
-
Inception date
Jul 23 2019
Listing date
Feb 16 2023
| Date | NAV (EUR) | Market price (EUR) |
|---|---|---|
| Oct 29 2026 | — | €60.5900 |
| Oct 28 2026 | €59.9826 | €60.0900 |
| Oct 27 2026 | €59.9361 | €60.0400 |
| Oct 26 2026 | €59.6693 | €59.8000 |
| Oct 23 2026 | €59.2250 | €59.2900 |
| Oct 22 2026 | €59.4090 | €59.5300 |
| Oct 21 2026 | €60.0235 | €60.1500 |
| Oct 20 2026 | €59.4857 | €59.6200 |
| Oct 19 2026 | €59.5682 | €59.6200 |
| Oct 16 2026 | €60.0465 | €60.1400 |
Purchase information
Currencies and stock exchanges
Listed currencies: EUR, GBP, USD, CHF
Base currency:EUR
Exchanges: NYSE Euronext - Amsterdam, London Stock Exchange, Deutsche Boerse, Bolsa Institucional De Valores, Borsa Italiana S.p.A., SIX Swiss Exchange